developed a dual cross-linked hydrogel system, P-aTIGIT&PDA@IL-15@gel, capable of sustained release of IL-15 and anti-TIGIT, effectively reactivating CD8+T cells and NK cells, and inhibiting residual tumor growth and distant metastasis in mouse PC models (159). Here, CD8A is linked to neoplasm.